Orbitopatía distifroidea después de yodoterapia en enfermedad de graves
- Autores:
-
Medina Orjuela, Adriana
Rojas, William
Hernández, María Clemencia
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2004
- Institución:
- Fundación Universitaria de Ciencias de la Salud - FUCS
- Repositorio:
- Repositorio Digital Institucional ReDi
- Idioma:
- spa
- OAI Identifier:
- oai:repositorio.fucsalud.edu.co:001/2254
- Acceso en línea:
- https://repositorio.fucsalud.edu.co/handle/001/2254
https://doi.org/10.31260/RepertMedCir.v13.n2.2004.346
- Palabra clave:
- Rights
- openAccess
- License
- Fundación Universitaria de Ciencias de la Salud FUCS - 0
| id |
FUCS2_b335b81a8135cb809f14294ad0e18c8b |
|---|---|
| oai_identifier_str |
oai:repositorio.fucsalud.edu.co:001/2254 |
| network_acronym_str |
FUCS2 |
| network_name_str |
Repositorio Digital Institucional ReDi |
| repository_id_str |
|
| dc.title.spa.fl_str_mv |
Orbitopatía distifroidea después de yodoterapia en enfermedad de graves |
| dc.title.translated.eng.fl_str_mv |
Dysthyroid orbitopathy after radiotherapy in severe disease |
| title |
Orbitopatía distifroidea después de yodoterapia en enfermedad de graves |
| spellingShingle |
Orbitopatía distifroidea después de yodoterapia en enfermedad de graves |
| title_short |
Orbitopatía distifroidea después de yodoterapia en enfermedad de graves |
| title_full |
Orbitopatía distifroidea después de yodoterapia en enfermedad de graves |
| title_fullStr |
Orbitopatía distifroidea después de yodoterapia en enfermedad de graves |
| title_full_unstemmed |
Orbitopatía distifroidea después de yodoterapia en enfermedad de graves |
| title_sort |
Orbitopatía distifroidea después de yodoterapia en enfermedad de graves |
| dc.creator.fl_str_mv |
Medina Orjuela, Adriana Rojas, William Hernández, María Clemencia |
| dc.contributor.author.spa.fl_str_mv |
Medina Orjuela, Adriana Rojas, William Hernández, María Clemencia |
| publishDate |
2004 |
| dc.date.accessioned.none.fl_str_mv |
2004-06-01 00:00:00 2022-02-21T20:35:38Z |
| dc.date.issued.none.fl_str_mv |
2004-06-01 |
| dc.date.available.none.fl_str_mv |
2004-06-01 00:00:00 2022-02-21T20:35:38Z |
| dc.type.spa.fl_str_mv |
Artículo de revista |
| dc.type.eng.fl_str_mv |
Journal article |
| dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
| dc.type.driver.spa.fl_str_mv |
info:eu-repo/semantics/article |
| dc.type.version.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.content.spa.fl_str_mv |
Text |
| dc.type.coarversion.spa.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| format |
http://purl.org/coar/resource_type/c_6501 |
| status_str |
publishedVersion |
| dc.identifier.doi.none.fl_str_mv |
10.31260/RepertMedCir.v13.n2.2004.346 |
| dc.identifier.issn.none.fl_str_mv |
0121-7372 |
| dc.identifier.uri.none.fl_str_mv |
https://repositorio.fucsalud.edu.co/handle/001/2254 |
| dc.identifier.eissn.none.fl_str_mv |
2462-991X |
| dc.identifier.url.none.fl_str_mv |
https://doi.org/10.31260/RepertMedCir.v13.n2.2004.346 |
| identifier_str_mv |
10.31260/RepertMedCir.v13.n2.2004.346 0121-7372 2462-991X |
| url |
https://repositorio.fucsalud.edu.co/handle/001/2254 https://doi.org/10.31260/RepertMedCir.v13.n2.2004.346 |
| dc.language.iso.spa.fl_str_mv |
spa |
| language |
spa |
| dc.relation.references.spa.fl_str_mv |
Jones, B, Kwok C, Kung A. Effect ofradioactive iodine therapy on cytokine production in Graves'disease; transient increases IL-10 and tumor necrosis factorin interleukin-4 alpha, with longer term increases in interferon-gamma production. J Clin Endocrinol Metab 1999; 84 (11). Weetman, Antonhy. Graves' Disease. N Engl J Med 2000; 343 (17):1236-48. Marcocci, Bartalena L, Tanda, M L. Comparison of the Effectiveness and Tolerability of Intravenous or Oral Glucocorticoids Associated with Orbital Radiotherapy in the Management of Severe Graves' Ophthalmopathy: Results of a Prospective, Single-Blind, Randomized Study. J Clin Endocrinol Metab 2001; 86: 3562-67. Wiersinga W, Prummel M. An evidence-based approach to the treatment of graves' ophthalmopathy . Endocrinol Metab Clin North Am 2002; 29 (2). Bahn RS, Gorman CA. Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalmopathy. Endocrinol Metab Clin North Am 1987; 16:391-407. Bartalena L, Marcocci C, Bogazzi F. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 1989; 321: 1349-52. Bartalena L, Marcocci C, Bogazzi F, Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 1998; 338: 73-8. Bartalena L, Marcocci C, Tanda ML. Cigarette smoking and treatment outcomes in Graves' ophthalmopathy. Ann Intera Med 1998; 129: 623-35. Wierssinga W. Preventing Graves' ophthalmopathy. N Engl J Med 1998; 338: 121-22. Bonavolonta G, Muto P, Lombardi, Gaetano. Orbital Scintigraphy with [111 In-Diethylenetriamine Pentaacetic Acid-D-Phel ]-Octreotide Predicts the Clinical Response to Corticosteroid Therapy in Patients with Graves' Ophthalmopath. J clin Endocrinol Metab 1998; 83 (11). Kahaly G, Rosler, H P, Pitz, S. Low- Versus High-Dose Radiotherapy for Graves' Ophthalmopathy: A Randomized, Single Blind Trial. J clin Endocrinol Metab 2003; 85 (1). Wiersinga W, Prummel M F Pathogenesis of Graves' Ophthalmopathy-Current Understanding. J Clin Endocrinol Metab 2001; 86 (2). Smith T, Koumas L, Gagnnon AM, Bell , A. Orbital Fibroblast Heterogeneity May Determine the Clinical Presentation of Thyroid-Associated Ophtalmopathy. J clin Endocrinol Metab 2002; 87 (1). Bartalena L, Tana, M L, Manetti, L. Comparison of the Effectiveness and Tolerability of Intravenous or Oral Glucocorticoids Associated with Orbital Radiotherapy in the Management of Severe Graves' Ophthalmopathy: Results of a Prospective, Single-Blind, Randomized Study. J Clin Endocrinol Metab 2001; 86 (8). Dieguez C, Pavia, C, Yturriaga, R. Tiroides. Madrid, McGraw Hila, Interamericana, 1999, p. 244. Greenspan F, Strewler G Endocronologia Básica y Clinica. México, Manual Moderno, 1997, p 267-269. Tallsted L, Lundell , G, Torring, O et al. Ocurrence of ophthalmopathy after treatment for Graves hiperthyroidism. N Engl J Med 1999; 326: 1733. Wengrowicz S E. Prevención de la oftalmopatía tiroidea. Endocrinol Nut..2001; 48 (3). Bartalena L, Marcocci, C and Pinchera A. Graves 'ophthal- mopathy: a preventable disease? Eur J Endocrinol 2002; 146:457-61. |
| dc.relation.bitstream.none.fl_str_mv |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/346/374 |
| dc.relation.citationedition.spa.fl_str_mv |
Núm. 2 , Año 2004 : Abril – Junio |
| dc.relation.citationendpage.none.fl_str_mv |
77 |
| dc.relation.citationissue.spa.fl_str_mv |
2 |
| dc.relation.citationstartpage.none.fl_str_mv |
72 |
| dc.relation.citationvolume.spa.fl_str_mv |
13 |
| dc.relation.ispartofjournal.spa.fl_str_mv |
Revista Repertorio de Medicina y Cirugía |
| dc.rights.spa.fl_str_mv |
Fundación Universitaria de Ciencias de la Salud FUCS - 0 |
| dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.uri.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc-sa/4.0/ |
| dc.rights.coar.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| rights_invalid_str_mv |
Fundación Universitaria de Ciencias de la Salud FUCS - 0 https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.mimetype.spa.fl_str_mv |
application/pdf |
| dc.publisher.spa.fl_str_mv |
Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud |
| dc.source.spa.fl_str_mv |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/346 |
| institution |
Fundación Universitaria de Ciencias de la Salud - FUCS |
| bitstream.url.fl_str_mv |
https://repositorio.fucsalud.edu.co/bitstreams/60b641ae-15da-4cd4-a88c-994e4cb05af8/download |
| bitstream.checksum.fl_str_mv |
6196f8c8a4400a9ccee2150be0626249 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 |
| repository.name.fl_str_mv |
Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud |
| repository.mail.fl_str_mv |
redi@fucsalud.edu.co |
| _version_ |
1831931102944559104 |
| spelling |
Medina Orjuela, Adrianac236d710b370e3fe02f6c0dee080bdd8500Rojas, Williamc1d10fe4923393188d8d69f64877a441500Hernández, María Clemenciac46f671a33f1b5d82425dbf0a1af2f333002004-06-01 00:00:002022-02-21T20:35:38Z2004-06-012004-06-01 00:00:002022-02-21T20:35:38ZSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la SaludFundación Universitaria de Ciencias de la Salud FUCS - 0info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/346Orbitopatía distifroidea después de yodoterapia en enfermedad de gravesDysthyroid orbitopathy after radiotherapy in severe diseaseapplication/pdfArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/coar/version/c_970fb48d4fbd8a8510.31260/RepertMedCir.v13.n2.2004.3460121-7372https://repositorio.fucsalud.edu.co/handle/001/22542462-991Xhttps://doi.org/10.31260/RepertMedCir.v13.n2.2004.346spaJones, B, Kwok C, Kung A. Effect ofradioactive iodine therapy on cytokine production in Graves'disease; transient increases IL-10 and tumor necrosis factorin interleukin-4 alpha, with longer term increases in interferon-gamma production. J Clin Endocrinol Metab 1999; 84 (11).Weetman, Antonhy. Graves' Disease. N Engl J Med 2000; 343 (17):1236-48.Marcocci, Bartalena L, Tanda, M L. Comparison of the Effectiveness and Tolerability of Intravenous or Oral Glucocorticoids Associated with Orbital Radiotherapy in the Management of Severe Graves' Ophthalmopathy: Results of a Prospective, Single-Blind, Randomized Study. J Clin Endocrinol Metab 2001; 86: 3562-67.Wiersinga W, Prummel M. An evidence-based approach to the treatment of graves' ophthalmopathy . Endocrinol Metab Clin North Am 2002; 29 (2).Bahn RS, Gorman CA. Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalmopathy. Endocrinol Metab Clin North Am 1987; 16:391-407.Bartalena L, Marcocci C, Bogazzi F. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 1989; 321: 1349-52.Bartalena L, Marcocci C, Bogazzi F, Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 1998; 338: 73-8.Bartalena L, Marcocci C, Tanda ML. Cigarette smoking and treatment outcomes in Graves' ophthalmopathy. Ann Intera Med 1998; 129: 623-35.Wierssinga W. Preventing Graves' ophthalmopathy. N Engl J Med 1998; 338: 121-22.Bonavolonta G, Muto P, Lombardi, Gaetano. Orbital Scintigraphy with [111 In-Diethylenetriamine Pentaacetic Acid-D-Phel ]-Octreotide Predicts the Clinical Response to Corticosteroid Therapy in Patients with Graves' Ophthalmopath. J clin Endocrinol Metab 1998; 83 (11).Kahaly G, Rosler, H P, Pitz, S. Low- Versus High-Dose Radiotherapy for Graves' Ophthalmopathy: A Randomized, Single Blind Trial. J clin Endocrinol Metab 2003; 85 (1).Wiersinga W, Prummel M F Pathogenesis of Graves' Ophthalmopathy-Current Understanding. J Clin Endocrinol Metab 2001; 86 (2).Smith T, Koumas L, Gagnnon AM, Bell , A. Orbital Fibroblast Heterogeneity May Determine the Clinical Presentation of Thyroid-Associated Ophtalmopathy. J clin Endocrinol Metab 2002; 87 (1).Bartalena L, Tana, M L, Manetti, L. Comparison of the Effectiveness and Tolerability of Intravenous or Oral Glucocorticoids Associated with Orbital Radiotherapy in the Management of Severe Graves' Ophthalmopathy: Results of a Prospective, Single-Blind, Randomized Study. J Clin Endocrinol Metab 2001; 86 (8).Dieguez C, Pavia, C, Yturriaga, R. Tiroides. Madrid, McGraw Hila, Interamericana, 1999, p. 244.Greenspan F, Strewler G Endocronologia Básica y Clinica. México, Manual Moderno, 1997, p 267-269.Tallsted L, Lundell , G, Torring, O et al. Ocurrence of ophthalmopathy after treatment for Graves hiperthyroidism. N Engl J Med 1999; 326: 1733.Wengrowicz S E. Prevención de la oftalmopatía tiroidea. Endocrinol Nut..2001; 48 (3).Bartalena L, Marcocci, C and Pinchera A. Graves 'ophthal- mopathy: a preventable disease? Eur J Endocrinol 2002; 146:457-61.https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/346/374Núm. 2 , Año 2004 : Abril – Junio7727213Revista Repertorio de Medicina y CirugíaPublicationOREORE.xmltext/xml2523https://repositorio.fucsalud.edu.co/bitstreams/60b641ae-15da-4cd4-a88c-994e4cb05af8/download6196f8c8a4400a9ccee2150be0626249MD51001/2254oai:repositorio.fucsalud.edu.co:001/22542024-02-02 13:10:28.422https://creativecommons.org/licenses/by-nc-sa/4.0/Fundación Universitaria de Ciencias de la Salud FUCS - 0metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co |